(Q45745717)

15 December 2017

title

Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants (English)

1 reference

15 December 2017

1 reference

Jardi R

1

1 reference

15 December 2017

Buti M

2

1 reference

15 December 2017

Rodriguez-Frias F

3

1 reference

15 December 2017

Cotrina M

4

1 reference

15 December 2017

Costa X

5

1 reference

15 December 2017

Pascual C

6

1 reference

15 December 2017

Esteban R

7

1 reference

15 December 2017

Guardia J

8

1 reference

15 December 2017

publication date

1 December 1999

1 reference

15 December 2017

Journal of Virological Methods

published in

1 reference

15 December 2017

volume

83

1 reference

15 December 2017

issue

1-2

1 reference

15 December 2017

page(s)

181-187

1 reference

15 December 2017

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900125-1

7 January 2021

Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900125-1

7 January 2021

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900125-1

7 January 2021

Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900125-1

7 January 2021

Therapy of viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900125-1

7 January 2021

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900125-1

7 January 2021

Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900125-1

7 January 2021

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900125-1

7 January 2021

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900125-1

7 January 2021

Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900125-1

7 January 2021

Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900125-1

7 January 2021

10.1016/S0166-0934(99)00125-1

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

10598095

1 reference

15 December 2017